Public access to publicly funded research: how and why mandatory policies by funders? by Giglia, Elena
Public access to publicly funded research: how and why mandatory policies by funders? 
Elena Giglia, 
Università degli Studi di Torino, elena.giglia@unito.it 
 
Abstract 
This contribution is aimed at presenting the principles upon which rely the mandatory Open Access 
policies of over 40 funding organizations worldwide. Most of them are in the biomedical field. 
Policies require that outputs of research publicly funded must be publicly available by self-
archiving in an Open Archive. One of the latest funders to adopt such a policy is Telethon 







In the latest years several funders and public organizations at national and international level 
claimed with public statements for free access to publicly funded research: among the others, UN 
World summit on Information Society in 2003, OECD in 2004, US National Institutes of Health in 
2007/8, European Research Council in 2008, European Union in 2010 [1]. 
The underlying principle is that publicly funded research outputs have to be publicly available. This 
is one of the key aspects of the Open Access movement we were talking about in our last column: 
Open Access means free, unrestricted, immediate access to peer-reviewed literature for anyone, 
anywhere, in any time [2]. 
A free access actually fosters and speeds up scientific progress, and a wider dissemination 
maximizes the impact of any research. Moreover, as John Houghton puts it, «Because discovery is a 
cumulative process, with new knowledge building on earlier findings, the dissemination of research 
findings is crucial to ensuring that the returns on the investment are realized» [3]. Funding agencies 
are sensitive to these arguments. 
Based on this logic, they are adopting “mandatory policies”: it means that a funder requires the 
results stemming from researches granted by its funds to be publicly available. Please notice that no 
mandatory policy requires Open Access “publishing” in an Open Access journal (so called Gold 
road to OA); policies just mandate “depositing” in an Open Archive the pre-print or post-print of 
the work published in a traditional scientific journal, according to the publishers‟ copyright 
agreement (so called Green road to OA). As we stressed in our last column, Green road or self-
archiving is an immediate way to provide Open Access: it relies upon the author‟s choice and 
willing, it is at basically zero costs, and takes only few minutes to deposit; in return the paper 
becomes immediately more visible, more usable and therefore potentially more citable. If a 
researcher chooses (but it‟s a free choice) to publish in an Open Access journal which requires an 
Article Processing Fee, many funders pay the fee; the European Union reimburse it [4]. 
Mandatory policies are growing day by day. In the biomedical field, the most striking examples are 
represented by National Health and Medical Research Council (Australia), Canadian Institutes of 
Health Research (Canada), INSERM (France, only “encourages” not “requires”), Health Research 
Board (Ireland), Medical Research Council (UK) and of course NIH (USA). On this same path, the 
FRPAA – Federal Research Public Access Act 
(http://www.arl.org/sparc/advocacy/frpaa/index.shtml) is being debated in the US Senate to extend 
the Public Access policy to all the 11 National research Agencies. We talked about NIH and its 
policy in our last column. 
A list of both institutional and funders‟ policies is available in the ROARMAP project 
(http://www.eprints.org/openaccess/policysignup/): as of October, 30
th
 there are 244 policies 
worldwide, and 21 proposed policies under debate. The SHERPA-JULIET project 
(http://www.sherpa.ac.uk/juliet/) lists only the funders‟ policies: it details whether, what, when and 
where to deposit. Mandatory policies in fact can require a specific archive or can sometimes tolerate 
an “embargo” period of 6 or 12 months, i.e. a delay in deposit after publication. SHERPA-JULIET 
works in parallel to and is connected to the SHERPA-RoMEO project 
(http://www.sherpa.ac.uk/romeo/), which lists the publishers‟ copyright policies according to which 
you can or can‟t deposit your work. When you run a search for your journal or publisher in 
RoMEO, the database shows immediately the compliance with any funders‟ mandate. Fig.1 give an 
example of the copyright policy of Nature Publishing Group, publisher of «Spinal cord»: they allow 
the immediate deposit of pre-print, and the deposit of post-print with a six-month embargo, being 
compliant with many funders‟ mandates. 
Let‟s see some of the policies which might affect researchers in Europe in the biomedical field. 
 
Fig 1: copyright policy for «Spinal cord» and compliance with funders‟ mandate. 
 
European Union Open Access Pilot Project 
 
At an institutional level, the European Union promotes openness for the benefit of innovation, and 
facilitates the diffusion of knowledge in its three roles of policy-making body, funding body, and 
capacity-making body. The European Community Treaty (Lisbon Treaty) states that «Union shall 
have the objective of strengthening its scientific and technological bases by achieving a European 
Research Area in which researchers, scientific knowledge and technology circulate freely» [5]. 
ERA, the European Research Area, is supported mostly by two initiatives. The first one is “A 
Digital Agenda for Europe” (COM(2010)245). In point 5.2.5 we read «publicly funded research 
should be widely disseminated through Open Access publication of scientific data and papers», in 
order to support which «the Commission will appropriately extend current Open Access publication 
requirements». The second Communication, “Innovation Union” (COM(2010)546) is based on the 
so called "fifth freedom", which is not only the free movement of researchers but also the free 
movement of innovative ideas. The Commitment 20 states: «The Commission will promote open 
access to the results of publicly funded research.  It will aim to make open access to publications the 
general principle for projects funded by the EU research Framework Programs» [6]. 
Within the current Seventh Framework Program, the Open Access Pilot project 
(http://tinyurl.com/2f47hwh) mandates that each researcher granted by the EU in six pilot 
disciplines must deposit the outputs in an Open Archive. 
“Health” is one of the selected six disciplines. Open Archives are repositories of digital objects; 
they can be institutional or subject-based. In Europe, UKPubMedCentral (http://ukpmc.ac.uk/) is 
the most complete Open Archive in Biomedicine. A list of biomedical Open Archives can be 
browsed or searched in DOAR – Directory of Open Access Repositories 
(http://tinyurl.com/38dxkh8). A list of publishers‟ copyright policies is displayed in the SHERPA-
RoMEO project (http://www.sherpa.ac.uk/romeo/): of course, you can archive your work only 
according to your publisher‟s policy. For those who give no permission, it is possible however to 
deposit metadata only. A Guide to Intellectual Property Rules in 7FP is also available 
(ftp://ftp.cordis.europa.eu/pub/fp7/docs/ipr_en.pdf). 
The European project OPENAIRE (http://www.openaire.eu/) is aimed at establishing underlying 
structures for researchers to support them in complying with the Open Access Pilot, including a 
central repository. 
 
Wellcome Trust, Telethon Foundation and the others 
 
In the biomedical field, Wellcome Trust (http://www.wellcome.ac.uk/) has been a pioneer: in 
October, 2006, it became one of the first research funding agencies in the world to require Open 
Access to all publications resulting from its grants.  
Sir Marc Walport, Director of Wellcome Trust, stresses in a short but pregnant video that any 
research is not complete until published [7]. “Published” has to be considered in its etymological 
meaning of “made public” to anyone, anywhere, anytime. By maximizing the dissemination of the 
research outputs, the impact is also maximized and therefore the value of a funded research. In 
2009, the compliance with the policy was at 44% [8]. Wellcome Trust was among 
UKPubMedCentral funding organizations; its policy has been a template for several other funding 
bodies. 
Telethon Foundation (http://www.telethon.it/english/default.aspx) adopted a mandatory Open 
Access policy in July, 2010. In their statement we read «Telethon therefore supports unrestricted 
access to the published output of research as a fundamental part of its charitable mission and a 
public benefit to be encouraged wherever possible», which sounds like a keen commitment towards 
Open Access [9]. Telethon joined UKPubMedCentral project, and shares its common approach. 
UKPubMedCentral is also the designed open archive where to deposit. Telethon accepts an 
embargo of maximum six months; if the publisher does not comply, Telethon can provide authors 
covering the fees for the “Open Choice” many traditional scientific publishers offer (i.e. under the 
payment of a fee, the article is immediately put Open Access even in a subscription-based journal). 
 
Advantages, or: in return of Open Access Policies 
 
The biomedical scientific community receives benefits from papers made freely available in Open 
Access both as information producer and information consumer. 
As authors, researchers increase their visibility and their impact. Their papers, widely disseminated, 
become more usable and therefore potentially more citable. Studies on the citation advantage in 
Open Access show a 300/450% increase in citations in Medicine [10]. Moreover, they can have an 
impact not only on the academic community, but on the whole medical community, i.e. the 
practitioners who read, work, keep up to date but don‟t publish and therefore don‟t cite. 
As readers, researchers can have free access to a growing number of peer-reviewed papers. A recent 
study by Björk et al. on articles published in 2008 finds that in average 20, 4% of the current 
scientific literature is available in some form of Open Access [11]. If you run a search in PubMed 
for “muscular dystrophy physical treatment” you get 433 articles, 76 of which (18%) results as “free 
full text” in the Filters at the right upper end of the result page. If you run a search for “stroke 
rehabilitation” you find 2,640 free full texts out of 12,916 (20%). According to what we have said 
about Open Access mandatory policies, a further advantage is that this (growing) 20% represents 
the results of researchers funded – and therefore selected and evaluated among lots, before funding 
– by prestigious funding bodies. It is an indirect seal of quality. 
As readers and reviewers, a wider access ensures most accurate reviews; it avoids inefficient 
duplications; and enhances international and interdisciplinary collaborations. 
A last advantage for researchers as readers is that the availability of free full text enables new 
technologies like text mining and data mining which unlock easier and more effective paths to the 
researchers, fostering and speeding the progress of knowledge. The cited UKPubMedCentral 
(http://ukpmc.ac.uk/) offer new value-added services: sensors techniques operating on open data 
and texts open direct, seamless connections from relevant terms found within abstracts and full-text 
article to gene, protein and chemical compound free databases, such as UniProt 
(http://www.uniprot.org/) and CheBI (http://www.ebi.ac.uk/chebi/). You can access these sources 
directly from your retrieved items, opening the “Bioentities” label displaying above the record or 
looking at the box on the right side of the screen (Fig. 2). Then a list of bioentities found in the full 
text appears, and just by clicking on the term you can quickly access external reliable sources with 
pre set searches right for this term. Research becomes quicker, broader, more effective and surely 
time-saving. 
 
Fig. 2 UKPubMedCentral text mining with link to external sources for Bioentities 
  







[2] Giglia, E. Open access to scientific research: where are we and where are we going? Facts and 
figures on the occasion of the 2010 Open Access Week (October 18-24), European Journal of 




[3] Houghton, J, Economic and Social Return on Investment in Open Archiving Federally Funded 
Research Outputs, Report, August 2010. Available at http://www.cfses.com/FRPAA/. 
 
[4] Funder policies and fee payments (BioMedCentral), 
http://www.biomedcentral.com/info/authors/funderpolicies; FP7 Grant Agreement – Annex II – Par. 
II.16, available at ftp://ftp.cordis.europa.eu/pub/fp7/docs/fp7-ga-annex2_en.pdf, p. 18.  
 
[5] Consolidated version of the Treaty on the Functioning of the European Union, art. 179. 
Available at http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2010:083:0047:0200:EN:PDF, p. 128 
 
[6] See respectively „A Digital Agenda for Europe‟ (COM(2010)245), available at 
http://ec.europa.eu/information_society/digital-agenda/documents/digital-agenda-communication-
en.pdf, p. 23; and “Innovation Union” (COM(2010)546), available at 
http://www.leru.org/files/general/innovation-union-communication_en.pdf, p. 19. See also 
Ramjoué, C. Open Access in the European Research Area, 2010, available at 
http://hdl.handle.net/2318/714. 
 
[7] See http://www.wellcome.ac.uk/About-us/Policy/Spotlight-issues/Open-access/index.htm.  
 
[8] Kiley, R. Analysis of where Wellcome-funded authors publish: 2009 data, blog post, 1 July 
2010. Available at http://ukpmc.blogspot.com/2010/07/analysis-of-where-wellcome-funded.html. 
 
[9] Telethon Open Access policy, available at 
http://www.telethon.it/sites/researchers/open/default.aspx. 
 
[10] See the table in Swan, A. The Open Access citation advantage: Studies and results to date. 
Technical Report, 2010, available at http://eprints.ecs.soton.ac.uk/18516/, p. 18. 
 
[11] Björk, B.C. et al. 2010 Open Access to the Scientific Journal Literature: Situation 2009. 
PLoS ONE 5(6): e11273, available at 
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0011273. 
 
